iSpecimen Inc. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
iSpecimen Inc. (ISPC) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $1.10 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2026-08-14
- iSpecimen Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2025-06-30 was $1.10K, a 97.82% decline year-over-year.
- iSpecimen Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2024-06-30 was $50.44K.
- iSpecimen Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2024-03-31 was $204.84K.
- iSpecimen Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2021-06-30 was $2.34M.
- iSpecimen Inc. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2021 was $2.34M.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 12 month |
|---|---|---|---|
| 2025-06-30 | $1.10K 10-Q · filed 2026-08-14 | ||
| 2024-06-30 | $50.44K 10-Q · filed 2024-11-07 | $255.29K derived: sum of 2 quarters · filed 2025-05-19 | |
| 2024-03-31 | $204.84K 10-Q · filed 2025-05-19 | ||
| 2021-12-31 | $2.34M 10-K/A · filed 2023-03-30 | ||
| 2021-06-30 | $2.34M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |